Fundraising Fox

Invus2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

MOMA Therapeuticsmomatx.comin𝕏May 2022 · $150M

A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.

Biotech

Timur Yusufzai(Founder)inAsit Parikh(Chief Executive Officer)in

Co-investorsNextech InvestThird Rock VenturesAlexandriaCasdin CapitalCreacion VenturesGoldman Sachs+3 more

Sironaxsironax.comin𝕏Aug 2022 · $200M

Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases.

BiotechHealthtechLongevityWaltham, US

Dr. Xiaodong Wang(Founder)Dr. Zhiyuan Zhang(Founder)

Co-investorsARCH Venture PartnersF-Prime CapitalYuanBio Venture CapitalCBC GroupEight Roads VenturesFuture Innovation+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.